Europe Injectable Drug Delivery Market 2025: Focus on Companies, Opportunities, Challenges, Drivers, Growth, Countries, Revenue & Forecast
Major factors contributing to the growth of the market includes factors such rising cases of chronic diseases and due to rising demand of self-injection devices. On the other hand needle stick injuries and infections may hinder the growth of the market.
(EMAILWIRE.COM, May 15, 2018 ) The Europe injectable drug delivery market is expected to USD 369,668.94 million by 2025, from USD 122,906.09 million in 2017 growing at a CAGR of 12.8% in the forecast period 2018 to 2025
Ask for Free Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=europe-injectable-drug-delivery-market
Covered in this report
The report covers the present scenario and the growth prospects of the Europe injectable drug delivey market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.
The key market players for Europe injectable drug delivery market are listed below:
Baxter International, Inc.,
Becton Dickinson and Company,
Gerresheimer AG,
Pfizer, Inc.,
Schott AG,
Alkermes Plc.,
Eli Lilly and Company,
Sandoz,
Terumo Corporation,
Teva Pharmaceuticals Industries Ltd.
Ypsomed,
Bespak
Questions? Ask to Our Experts @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=europe-injectable-drug-delivery-market
The market is further segmented into:
Type
Usage Pattern
End-User
Mode of Administration
Distribution Channel
Application
Geography
The Europe injectable drug delivery market is segmented on of type, portability, type, product type, and application, and usage pattern, mode of administration, end user, distribution channel, and geography. The report provides data for 2016 to 2025, 2017 being the current year while 2018 to 2025 is the forecast period for the report.
The Europe injectable drug delivery market is segmented based on type into two notable segments; injectable drug delivery device and injectable drug delivery formulation. Injectable drug delivery device market is segmented into conventional injection devices and self-injection devices. The injectable drug delivery formulation is segmented into conventional drug delivery formulation and novel drug delivery formulation. The Injectable drug delivery market is dominated by formulations with 83.4% market share in 2018, growing at a CAGR of 12.6% and will cross USD 304,070.69 million by 2025
On the basis of application, the market is segmented into autoimmune disease, hormonal disorders, orphan diseases, oncology and others. The autoimmune diseases segment is further sub segmented based on indications into rheumatoid arthritis, multiple sclerosis, Crohns disease, psoriasis and others. Hormonal disorders are further segmented into indications such as diabetes, antithrombotic therapy, reproductive health diseases, anemia, osteoporosis and others. The Injectable drug delivery market is dominated by hormonal disorders with 48.3% market share in 2018, growing at a CAGR of 12.1% and will cross USD 169,847.17 million by 2025. However, oncology segment is expected to grow at the highest CAGR of 14.1% in the forecast period, and is expected to reach USD 84,577.41 million in 2025 from USD 25,259.88 million in 2017.
On the basis of usage pattern, the market is segmented into curative care, immunization and other usage pattern. The Injectable drug delivery market is dominated by curative care with 94.9% market share in 2018, growing at a CAGR of 12.8% and will cross USD 351,807.22 million by 2025.
Questions? Well Put You On The Right Path Request Analyst Call: http://databridgemarketresearch.com/speak-to-analyst/?dbmr=europe-injectable-drug-delivery-market
On the basis of mode of administration, the market is segmented into skin, circulatory/muskoskeletal, organs and central nervous system. The Injectable drug delivery market is dominated by skin with 48.1% market share in 2018, growing at a CAGR of 13.0% and will cross USD 179,882.71 million by 2025.
On the basis of end users, the market is classified into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others. The Injectable drug delivery market is dominated by hospitals & clinics with 61.8% market share in 2018, growing at a CAGR of 12.9% and will cross USD 230,052.79 million by 2025. However, home healthcare settings segment is expected to grow at the highest CAGR of 14.5% in the forecast period, and is expected to reach USD 79,428.60 million in 2025 from USD 22,963.21 million in 2017
On the basis of distribution channel, the market is classified into hospital pharmacies, pharmacy store, and direct tender and online pharmacy. The Injectable drug delivery market is dominated by direct tenders with 71.0% market share in 2018, growing at a CAGR of 13.0% and will cross USD 266,909.52 million by 2025. However, pharmacy stores segment is expected to grow at the highest CAGR of 14.0% in the forecast period, and is expected to reach USD 53,861.23 million in 2025 from USD 16,201.79 million in 2017.
Based on geography, the Europe injectable drug delivery market is segmented into geographical regions, such as,
Germany
United Kingdom
France
Spain
Italy
Russia
Turkey
Belgium
Nether lands
Switzerland
Rest of Europe
Click Here for Full Customize Report @ http://databridgemarketresearch.com/reports/europe-injectable-drug-delivery-market/
TABLE OF CONTENTS EUROPE INJECTABLE DRUG DELIVERY MARKET
1. Introduction
1.1. Overview Of Europe Injectable Drug Delivery Market
1.2. Currency And Pricing
1.3. Limitation
1.4. Markets Covered
2. Market Segmentation
2.1. Markets Covered
2.2. Geographic Scope
2.3. Years Considered For The Study
2.4. Currency And Pricing
2.5. Research Methodology
2.6. Primary Interviews With Key Opinion Leaders
2.7. Secondary Sources
2.8. Assumptions
3. Market Overview
3.1. Drivers
3.1.1. Rising Cases Of Chronic Diseases
3.1.2. Rising Demand Of Self-Injection Devices
3.1.3. Growth Of Biologics Market
3.1.4. Technological Advancements And Innovations In Drug Delivery Market
3.2. Restraints
3.2.1. Needlestick Injuries And Infections
3.2.2. High Cost Of Development
3.2.3. Strict Regulatory Framework
3.3. Opportunity
3.3.1. Increasing Demand For Generic And Biosimilar Drugs
3.3.1.1. Generics
3.3.1.2. Biosimilars
3.3.2. Increasing Demand For Contraceptive Injectables
3.3.3. Increasing Demand For Self-Administration Of Drugs
3.4. Challenges
3.4.1. Alternative Route Of Drug Administration
3.4.2. Product Recall
3.4.3. Stability Of Products
3.4.4. Sterility Of Injections
4. Executive Summary
5. Premium Insights
6. Europe Injectable Drug Delivery Market, Regulatory
6.1. Overview
6.2. U.S. Fda Approval
6.3. Ce Marking (European Conformity)
6.4. Em (European Medicine Agency)
7. Europe Injectable Drug Delivery Market, By Type
7.1. Overview
7.2. Injectable Drug Delivery Devices
7.2.1. Conventional Injection Devices
7.2.2. Self Injection Devices
7.2.2.1. Needle Free Injectors (Nfi)
7.2.2.2. Auto Injectors
7.2.2.3. Pen Injectors
7.2.2.4. Wearable Injectors
7.3. Injectable Drug Delivery Formulation
7.3.1. Conventional Drug Delivery Formulations
7.3.1.1. Solutions
7.3.1.2. Reconstituted/Lyophilized Formulations
7.3.1.3. Suspensions
7.3.1.4. Emulsions
7.3.2. Novel Drug Delivery Formulations
7.3.2.1. Colloidal Dispersions
7.3.2.2. Microparticles
7.3.2.3. Long Acting Injection Formulation
8. Europe Injectable Drug Delivery Market, By Application
8.1. Overview
8.2. Europe Injectable Drug Delivery Market, By Application
8.3. Hormonal Disorders
8.4. Oncology
8.5. Autoimmune Diseases
8.6. Orphan Disease
9. Europe Injectable Drug Delivery Market, By Usage Pattern
10. Europe Injectable Drug Delivery Market, By Mode Of Administration
11. Europe Injectable Drug Delivery Market, By End User
12. Europe Injectable Drug Delivery Market, By Distribution Channel
13. Europe Injectable Drug Delivery Market, By Geography
13.1. Overview
13.2. Europe Injectable Drug Delivery Market
14. Europe Injectable Drug Delivery Market, Company Share
15. Company Profiles
15.1. Becton, Dickinson And Company
15.2. Pfizer
15.3. Baxter International
15.4. Gerresheimer Ag
15.5. Schott Ag Inc.
15.6. Alkermes Inc.
15.8. Bespak (Subsidiary Of Consort Medical Company)
15.9. Elcam Medical
15.10. Eli Lilly And Company
16. Related Reports
Related Report
Global Injectable Drug Delivery Market Industry Trends and Forecast to 2024
Global Injectable Drug Delivery Market, By Type (Devices, Formulations), Applications (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Oncology), Usage Pattern (Curative Care, Immunizations), Mode of Administration (Skin, Circulatory, Organs, Central Nervous System), End User, Geography Industry Trends and Forecast to 2024
Report Access: http://databridgemarketresearch.com/reports/global-injectable-drug-delivery-market/
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
Ask for Free Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=europe-injectable-drug-delivery-market
Covered in this report
The report covers the present scenario and the growth prospects of the Europe injectable drug delivey market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.
You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.
The key market players for Europe injectable drug delivery market are listed below:
Baxter International, Inc.,
Becton Dickinson and Company,
Gerresheimer AG,
Pfizer, Inc.,
Schott AG,
Alkermes Plc.,
Eli Lilly and Company,
Sandoz,
Terumo Corporation,
Teva Pharmaceuticals Industries Ltd.
Ypsomed,
Bespak
Questions? Ask to Our Experts @ http://databridgemarketresearch.com/inquire-before-buying/?dbmr=europe-injectable-drug-delivery-market
The market is further segmented into:
Type
Usage Pattern
End-User
Mode of Administration
Distribution Channel
Application
Geography
The Europe injectable drug delivery market is segmented on of type, portability, type, product type, and application, and usage pattern, mode of administration, end user, distribution channel, and geography. The report provides data for 2016 to 2025, 2017 being the current year while 2018 to 2025 is the forecast period for the report.
The Europe injectable drug delivery market is segmented based on type into two notable segments; injectable drug delivery device and injectable drug delivery formulation. Injectable drug delivery device market is segmented into conventional injection devices and self-injection devices. The injectable drug delivery formulation is segmented into conventional drug delivery formulation and novel drug delivery formulation. The Injectable drug delivery market is dominated by formulations with 83.4% market share in 2018, growing at a CAGR of 12.6% and will cross USD 304,070.69 million by 2025
On the basis of application, the market is segmented into autoimmune disease, hormonal disorders, orphan diseases, oncology and others. The autoimmune diseases segment is further sub segmented based on indications into rheumatoid arthritis, multiple sclerosis, Crohns disease, psoriasis and others. Hormonal disorders are further segmented into indications such as diabetes, antithrombotic therapy, reproductive health diseases, anemia, osteoporosis and others. The Injectable drug delivery market is dominated by hormonal disorders with 48.3% market share in 2018, growing at a CAGR of 12.1% and will cross USD 169,847.17 million by 2025. However, oncology segment is expected to grow at the highest CAGR of 14.1% in the forecast period, and is expected to reach USD 84,577.41 million in 2025 from USD 25,259.88 million in 2017.
On the basis of usage pattern, the market is segmented into curative care, immunization and other usage pattern. The Injectable drug delivery market is dominated by curative care with 94.9% market share in 2018, growing at a CAGR of 12.8% and will cross USD 351,807.22 million by 2025.
Questions? Well Put You On The Right Path Request Analyst Call: http://databridgemarketresearch.com/speak-to-analyst/?dbmr=europe-injectable-drug-delivery-market
On the basis of mode of administration, the market is segmented into skin, circulatory/muskoskeletal, organs and central nervous system. The Injectable drug delivery market is dominated by skin with 48.1% market share in 2018, growing at a CAGR of 13.0% and will cross USD 179,882.71 million by 2025.
On the basis of end users, the market is classified into hospitals and clinics, home healthcare, research laboratories, pharmaceutical and biotechnological companies and others. The Injectable drug delivery market is dominated by hospitals & clinics with 61.8% market share in 2018, growing at a CAGR of 12.9% and will cross USD 230,052.79 million by 2025. However, home healthcare settings segment is expected to grow at the highest CAGR of 14.5% in the forecast period, and is expected to reach USD 79,428.60 million in 2025 from USD 22,963.21 million in 2017
On the basis of distribution channel, the market is classified into hospital pharmacies, pharmacy store, and direct tender and online pharmacy. The Injectable drug delivery market is dominated by direct tenders with 71.0% market share in 2018, growing at a CAGR of 13.0% and will cross USD 266,909.52 million by 2025. However, pharmacy stores segment is expected to grow at the highest CAGR of 14.0% in the forecast period, and is expected to reach USD 53,861.23 million in 2025 from USD 16,201.79 million in 2017.
Based on geography, the Europe injectable drug delivery market is segmented into geographical regions, such as,
Germany
United Kingdom
France
Spain
Italy
Russia
Turkey
Belgium
Nether lands
Switzerland
Rest of Europe
Click Here for Full Customize Report @ http://databridgemarketresearch.com/reports/europe-injectable-drug-delivery-market/
TABLE OF CONTENTS EUROPE INJECTABLE DRUG DELIVERY MARKET
1. Introduction
1.1. Overview Of Europe Injectable Drug Delivery Market
1.2. Currency And Pricing
1.3. Limitation
1.4. Markets Covered
2. Market Segmentation
2.1. Markets Covered
2.2. Geographic Scope
2.3. Years Considered For The Study
2.4. Currency And Pricing
2.5. Research Methodology
2.6. Primary Interviews With Key Opinion Leaders
2.7. Secondary Sources
2.8. Assumptions
3. Market Overview
3.1. Drivers
3.1.1. Rising Cases Of Chronic Diseases
3.1.2. Rising Demand Of Self-Injection Devices
3.1.3. Growth Of Biologics Market
3.1.4. Technological Advancements And Innovations In Drug Delivery Market
3.2. Restraints
3.2.1. Needlestick Injuries And Infections
3.2.2. High Cost Of Development
3.2.3. Strict Regulatory Framework
3.3. Opportunity
3.3.1. Increasing Demand For Generic And Biosimilar Drugs
3.3.1.1. Generics
3.3.1.2. Biosimilars
3.3.2. Increasing Demand For Contraceptive Injectables
3.3.3. Increasing Demand For Self-Administration Of Drugs
3.4. Challenges
3.4.1. Alternative Route Of Drug Administration
3.4.2. Product Recall
3.4.3. Stability Of Products
3.4.4. Sterility Of Injections
4. Executive Summary
5. Premium Insights
6. Europe Injectable Drug Delivery Market, Regulatory
6.1. Overview
6.2. U.S. Fda Approval
6.3. Ce Marking (European Conformity)
6.4. Em (European Medicine Agency)
7. Europe Injectable Drug Delivery Market, By Type
7.1. Overview
7.2. Injectable Drug Delivery Devices
7.2.1. Conventional Injection Devices
7.2.2. Self Injection Devices
7.2.2.1. Needle Free Injectors (Nfi)
7.2.2.2. Auto Injectors
7.2.2.3. Pen Injectors
7.2.2.4. Wearable Injectors
7.3. Injectable Drug Delivery Formulation
7.3.1. Conventional Drug Delivery Formulations
7.3.1.1. Solutions
7.3.1.2. Reconstituted/Lyophilized Formulations
7.3.1.3. Suspensions
7.3.1.4. Emulsions
7.3.2. Novel Drug Delivery Formulations
7.3.2.1. Colloidal Dispersions
7.3.2.2. Microparticles
7.3.2.3. Long Acting Injection Formulation
8. Europe Injectable Drug Delivery Market, By Application
8.1. Overview
8.2. Europe Injectable Drug Delivery Market, By Application
8.3. Hormonal Disorders
8.4. Oncology
8.5. Autoimmune Diseases
8.6. Orphan Disease
9. Europe Injectable Drug Delivery Market, By Usage Pattern
10. Europe Injectable Drug Delivery Market, By Mode Of Administration
11. Europe Injectable Drug Delivery Market, By End User
12. Europe Injectable Drug Delivery Market, By Distribution Channel
13. Europe Injectable Drug Delivery Market, By Geography
13.1. Overview
13.2. Europe Injectable Drug Delivery Market
14. Europe Injectable Drug Delivery Market, Company Share
15. Company Profiles
15.1. Becton, Dickinson And Company
15.2. Pfizer
15.3. Baxter International
15.4. Gerresheimer Ag
15.5. Schott Ag Inc.
15.6. Alkermes Inc.
15.8. Bespak (Subsidiary Of Consort Medical Company)
15.9. Elcam Medical
15.10. Eli Lilly And Company
16. Related Reports
Related Report
Global Injectable Drug Delivery Market Industry Trends and Forecast to 2024
Global Injectable Drug Delivery Market, By Type (Devices, Formulations), Applications (Autoimmune Diseases, Hormonal Disorders, Orphan Diseases, Oncology), Usage Pattern (Curative Care, Immunizations), Mode of Administration (Skin, Circulatory, Organs, Central Nervous System), End User, Geography Industry Trends and Forecast to 2024
Report Access: http://databridgemarketresearch.com/reports/global-injectable-drug-delivery-market/
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
Contact Information:
Data Bridge Market Research
Data Bridge Market Resea
Tel: +1-888-387-2818
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Data Bridge Market Research
Data Bridge Market Resea
Tel: +1-888-387-2818
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results